When Wegovy takes effect: a realistic timeline for the first weeks

The first pen is in the fridge and you're wondering when something will happen

You've taken your first 0.25 mg dose and you're watching the clock. This is where most people's expectations and reality part ways. At the starting dose, Wegovy is calibrated for tolerability, your digestive system needs time to adjust to a GLP-1 receptor agonist before the dose climbs to levels where substantial weight loss occurs. That said, the medicine begins acting on your brain's hunger signalling almost immediately. Many patients report that portions feel more satisfying, meals feel complete sooner, and the background hum of appetite is quieter, all within the first two weeks.

Nausea, if it appears, tends to peak in this early window too. It's an indication the medicine is doing something, not a reason to stop without speaking to your prescriber first. The broader range of effects Wegovy produces is worth reading before you start, so early experiences don't catch you off guard. Weight change at 0.25 mg is usually modest (often a kilogram or two over the first four weeks) and that is entirely expected. The starter dose was never designed to produce dramatic results.

One thing our prescribers hear most weeks: "I've been on it a month and I've only lost two kilos, is it working?" Almost always, yes. The dose hasn't reached its working level yet.

Weeks four to sixteen: dose increases are where the timeline shifts

Once your prescriber moves you up the schedule (to 0.5 mg, then 1.0 mg, then 1.7 mg) the appetite suppression deepens and the pace of weight change typically accelerates. Each increase brings another brief adjustment period, similar in character to the first, usually settling within one to two weeks. People who track their food intake during this phase often notice the reduction in calories is happening naturally rather than through effort: hunger cues arrive less often and feel less urgent.

Average weight loss across the STEP 1 trial at the 68-week mark was around 15% of body weight, but that figure represents the full maintenance-dose period, not the titration phase. A closer look at exactly how soon Wegovy begins working shows why comparing your week-eight result to the trial's endpoint figure sets an unfair benchmark. Progress during titration is real, it's just not the whole story yet.

If you're wondering about the practical rhythm of injections, guidance on timing your weekly Wegovy dose covers the detail on consistency and what happens if you miss a day. Consistency of day and time helps keep blood levels steady, which matters more as doses rise.

Three to six months: reaching maintenance and seeing the fuller picture

Most people reach the 2.4 mg maintenance dose around month five of treatment, assuming each titration step is tolerated. This is where the timeline to Wegovy's full effect really lands. Clinical trial participants at 2.4 mg, over 68 weeks, saw an average of roughly 15% body-weight reduction according to the STEP 1 study published in the New England Journal of Medicine. The 7.2 mg pen, approved by the MHRA in April 2026, reached around 20.7% average weight loss in trials at 72 weeks (approaching tirzepatide results) though that dose is for BMI ≥30 only and requires titration from the standard starting point.

The NHS medicines page for semaglutide provides a patient-level overview of what the medicine does and how effectiveness is monitored. NICE's appraisal of Wegovy (TA875) recommends reviewing progress at six months: if weight loss is below 5% of starting body weight at maintenance dose, continuing is reassessed. That threshold exists precisely because the medicine is genuinely effective for most people who reach and tolerate the maintenance dose, it isn't a guarantee, but it is the realistic expectation.

What slows or blunts the effect, and what the evidence actually says

A few things genuinely affect how quickly Wegovy works and how much it achieves. Calorie intake matters: semaglutide reduces appetite but doesn't override a high-calorie diet entirely, particularly in the early weeks before appetite suppression is at full strength. Physical activity isn't required for the medicine to work, but the trial data consistently shows better outcomes when it accompanies treatment. Sleep, stress and individual metabolic differences all play a role, and weight loss is rarely linear, plateaus of two to four weeks are common mid-treatment and don't mean the medicine has stopped working.

If after several months at your maintenance dose you're seeing little change, that's a clinical question for your prescriber rather than a reason to assume treatment has failed. What to do if Wegovy doesn't seem to be working covers the most common reasons and what can be explored. The cost of private treatment is a real consideration too, and our treatment page sets out what is included in the price. For anyone still deciding between treatment options, the weight-loss treatment overview covers what is licensed in the UK alongside Wegovy.

If you'd like a prescriber to review whether Wegovy is suitable for you, you can speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, with same-day dispatch once approved.